Table 3b.

Table3b

3b: MIBC (T2-T4aN0M0)	2020 week 9–22		2020 week 2–8		2020 week 9–12		2020 week 13–16		2020 week 17–22
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Radical cystectomy +/- NAC	0.79	0.58–1.08	0.87	0.59–1.29	1.09	0.67–1.77	0.80	0.47–1.34	0.62	0.40–0.97
Upfront radical cystectomy*	0.96	0.60–1.52	0.86	0.48–1.54	1.43	0.69–2.99	1.06	0.46–2.43	0.65	0.34–1.24
NAC + radical cystectomy*	1.04	0.66–1.66	1.16	0.65–2.07	0.70	0.33–1.45	0.94	0.41–2.16	1.54	0.81–2.93
Radiotherapy	1.09	0.75–1.58	0.57	0.33–0.98	0.81	0.43–1.52	1.37	0.77–2.43	1.13	0.68–1.88
Chemoradiotherapy	1.32	0.85–2.05	2.00	1.22–3.30	0.94	0.43–2.04	1.59	0.80–3.18	1.44	0.80–2.59
Other	1.05	0.58–1.92	0.81	0.35–1.86	1.18	0.48–2.91	0.48	0.11–2.04	1.30	0.60–2.79
No treatment	1.12	0.76–1.64	1.37	0.83–2.25	1.14	0.60–2.19	0.91	0.46–1.77	1.27	0.74–2.15

MIBC: Muscle Invasive Bladder Cancer; OR: Odds Ratio; 95% CI: 95% Confidence Interval; NAC: Neo-Adjuvant chemotherapy. *The odds of receiving upfront radical cystectomy or neo-adjuvant chemotherapy (followed by radical cystectomy) was calculated within the group of patients undergoing surgery.